Posts

Showing posts with the label Dainippon Sumitomo Pharma

Future of drugs-Diabetes_Ranirestat

Image
Drug Name Ranirestat Structure   Drug Code AS-3201 Synonym (3R)-2'-(4-bromo-2-fluorobenzyl)-1'H,2H,5H-spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetrone Molecular Formula C 17 H 11 BrFN 3 O 4 Innovator Dainippon Sumitomo Pharma PharmaKyorin Condition Diabetic nephropathy (Orphan drug status) Mechanism of Action Aldose reductase inhibitor Clinical Phase III in USA